Number of the records: 1

dostupnosť biologická

SYS		d001682
LBL		00000nx--j22000003--45--
005		20240119195507.2
100		$a 19990101csloy0103----ba0
152		$b mesh
250		$a dostupnosť biologická $8 slo
300	1-	$a 79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86 $8 eng
300	1-	$a Biopharmaceutics (1966-1974) $8 eng
300	1-	$a Drug Compounding (1966-1969) $8 eng
300	1-	$a Drugs (1966-1969) $8 eng
300	1-	$a Pharmacology (1966-1969) $8 eng
330	1-	$a The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. $8 eng
450		$a Availability Equivalency $5 e $8 eng
450		$a Bioavailability $5 e $8 eng
450		$a Physiologic Availability $5 e $8 eng
450		$a biodostupnosť $5 e $8 slo
450		$a dostupnosť fyziologická $5 e $8 slo
450		$a dostupnosť ekvivalentná $5 e $8 slo
686		$a G03.787.151
686		$a G07.690.725.129
750		$a Biological Availability $8 eng
801	-0	$a US $b DNLM $c 19990101
801	-2	$a SK $b BA006 $c 20070706
820		$a coordinate NIM with specific drug /pharmacokin $8 eng
980		$x M

Number of the records: 1